Immunocompromised children and young people are at no increased risk of severe COVID-19
Objectives We aimed to prospectively describe the incidence and clinical spectrum of SARS-
CoV-2 infection in immunocompromised paediatric patients in the UK. Methods From March
2020 to 2021 weekly questionnaires were sent to immunocompromised paediatric patients
or their parents. Information, including symptom presentation and SARS-CoV-2 PCR test
results, was collected from 1527 participants from 46 hospitals. Cross-sectional serology
was investigated in February and March 2021. Results Until the end of September 2020, no …
CoV-2 infection in immunocompromised paediatric patients in the UK. Methods From March
2020 to 2021 weekly questionnaires were sent to immunocompromised paediatric patients
or their parents. Information, including symptom presentation and SARS-CoV-2 PCR test
results, was collected from 1527 participants from 46 hospitals. Cross-sectional serology
was investigated in February and March 2021. Results Until the end of September 2020, no …
